Supera-CBD

N/A

Report date: 2023/10/20 16:25:45
NME

Base Information

Drug NameSupera-CBD
Drug Alias NameSupera-CBD
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCannabinoid CB2 receptor agonists
TargetsCannabinoid CB2 receptor
Therapy Area/IndicationsAcute Pain
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMymd Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesMymd Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsAcute Pain
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A